Xavier Armoiry (X Armoiry)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Topics

Systematic Review

Left Atrial Appendage

Top Venues

Journal of evidence-based medicine

European journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Manon Benmalek, Martin Connock, Léa Savio, Jean-François Obadia, Xavier Armoiry
Cost-effectiveness of left atrial appendage occlusion during cardiac surgery in France: An economic evaluation based on the LAAOS III study. PloS one 19 (5) (2024)
Manuela Montagnon, Yenfu Chen, Amy Grove, Jieun Park, Jean-François Obadia, Xavier Armoiry
Reconciling conflicting evidence in the evaluation of the MitraClip system: Assessment of and response to the MITRA-FR and COAPT trials by key stakeholders. Journal of evidence-based medicine 17 (2) (2024)
Manuela Montagnon, Yenfu Chen, Amy Grove, Jieun Park, Jean-François Obadia, Xavier Armoiry
Reconciling conflicting evidence in the evaluation of the MitraClip system: Assessment of and response to the MITRA-FR and COAPT trials by key stakeholders. Journal of evidence-based medicine (2024)
Manon Benmalek, Martin Connock, Léa Savio, Jean-François Obadia, Xavier Armoiry
Cost-effectiveness of left atrial appendage occlusion during cardiac surgery in France: An economic evaluation based on the LAAOS III study. PloS one 19 (5) (2024)
Manuela Montagnon, Yenfu Chen, Amy Grove, Jieun Park, Jean-François Obadia, Xavier Armoiry
Reconciling conflicting evidence in the evaluation of the MitraClip system: Assessment of and response to the MITRA-FR and COAPT trials by key stakeholders. Journal of evidence-based medicine 17 (2) (2024)
Martin Connock, Peter Auguste, Jean-François Obadia, Lazaros Andronis, Xavier Armoiry
Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair. PloS one 18 (1) (2023)
Martin Connock, Peter Auguste, Jean-François Obadia, Lazaros Andronis, Xavier Armoiry
Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair. PloS one 18 (1) (2023)
Martin Connock, Peter Auguste, Jean-François Obadia, Lazaros Andronis, Xavier Armoiry
Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair. PloS one 18 (1) (2023)
Martin Connock, Peter Auguste, Jean-François Obadia, Lazaros Andronis, Xavier Armoiry
Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair. PloS one 18 (1) (2023)
Martin Connock, Peter Auguste, Jean-François Obadia, Lazaros Andronis, Xavier Armoiry
Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair. PloS one 18 (1) (2023)
Martin Connock, Peter Auguste, Aude Capelle, Anna-Maria Hénaine, Jean-François Obadia, Xavier Armoiry
Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical risk. BMJ open 13 (3) (2023)
Martin Connock, Peter Auguste, Aude Capelle, Anna-Maria Hénaine, Jean-François Obadia, Xavier Armoiry
Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical risk. BMJ open 13 (3) (2023)
Martin Connock, Peter Auguste, Aude Capelle, Anna-Maria Hénaine, Jean-François Obadia, Xavier Armoiry
Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical risk. BMJ open 13 (3) (2023)
Martin Connock, Xavier Armoiry
Cost-effectiveness of the MitraClip device in secondary mitral regurgitation: comment upon the article by Estler et al. The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Xavier Armoiry, Martin Connock
Correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Cohen et al . Heart (British Cardiac Society) 108 (13) (2022)
Xavier Armoiry, Xia Wang-Steverding, Martin Connock, Amy Grove, Aileen Clarke, Tarunya Arun, Carl Counsell, Peter Auguste
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis. International journal of technology assessment in health care 38 (1) (2022)
Xavier Armoiry, Xia Wang-Steverding, Martin Connock, Amy Grove, Aileen Clarke, Tarunya Arun, Carl Counsell, Peter Auguste
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis. International journal of technology assessment in health care 38 (1) (2022)
Martin Connock, Peter Auguste, Xavier Armoiry
A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation; three case studies of treatments for glioblastoma multiforme. The European journal of health economics : HEPAC : health economics in prevention and care 22 (1) (2020)
Xavier Armoiry, Jean-François Obadia, Peter Auguste, Martin Connock
Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation. PloS one 15 (11) (2020)
Martin Connock, Xavier Armoiry, Alexander Tsertsvadze, G J Melendez-Torres, Pamela Royle, Lazaros Andronis, Aileen Clarke
Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials. BMC cancer 19 (1) (2019)
Martin Connock, Peter Auguste, Claude Dussart, Jacques Guyotat, Xavier Armoiry
Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model. Journal of neuro-oncology 143 (3) (2019)
Xavier Armoiry, Alexander Tsertsvadze, Martin Connock, Pamela Royle, G J Melendez-Torres, Pierre-Jean Souquet, Aileen Clarke
Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis. PloS one 13 (7) (2018)
U Sadeh-Gonik, N Tau, T Friehmann, S Bracard, R Anxionnat, A-L Derelle, R Tonnelet, Liang Liao, S Richard, Xavier Armoiry, Benjamin Gory
Thrombectomy outcomes for acute stroke patients with anterior circulation tandem lesions: a clinical registry and an update of a systematic review with meta-analysis. European journal of neurology 25 (4) (2018)
Xavier Armoiry, Jackie Sturt, Emma Elizabeth Phelps, Clare-Louise Walker, Rachel Court, Frances Taggart, Paul Sutcliffe, Anne-Marie Slowther, Helen Atherton
Digital Clinical Communication for Families and Caregivers of Children or Young People With Short- or Long-Term Conditions: Rapid Review. Journal of medical Internet research 20 (1) (2018)
Benjamin Gory, Xavier Armoiry, R Sivan-Hoffmann, M Piotin, M Mazighi, B Lapergue, R Blanc, F Turjman
A direct aspiration first pass technique for acute stroke therapy: a systematic review and meta-analysis. European journal of neurology 25 (2) (2017)